With two bills up for debate in the House this week aiming to stop surprise billing, research finds the average surprise bill post-surgery exceeds $2,000.
With drug costs on the rise — and insurers refusing to cover some prescriptions — even patients with insurance can find themselves facing high out-of-pocket costs or going without.
A study this month showed giving extra social services to the neediest patients didn't reduce hospital readmissions. Now health advocates say that might not be the right measurement of success.
Texas will enact a law on Jan. 1 to prevent consumers from getting hit with surprise medical bills. The law survived last-minute efforts to write rules that would have gutted it.
Lawmakers Thursday passed a bill to rein in drug costs. President Trump has vowed to veto it. But the plan shares a lot with other bipartisan efforts. Here's how it would work.
Texas passed a bipartisan law against surprise medical billing, but advocates warn that a proposed rule could severely weaken it, continuing to allow surprise bills in many situations.
"Street medicine" programs, like one in Atlanta, seek out people living in back alleys and under highways. The public health outreach improves patients' health and is cost-effective, hospitals find.
Surgeon and researcher Marty Makary traveled the country talking to people about their experiences with health care. He learned that costs are poisoning Americans' relationships with medicine.
Type 1 diabetes can be well managed with insulin if blood sugar is consistently monitored. But insurance rules can make it hard for patients to get the medical supplies their doctors say they need.
The snakebite antivenin CroFab, on the U.S. market since 2000, now faces competition from a drug called Anavip. But both are expensive. "Perverse incentives" keep prices high, says one legal scholar.